| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2023 | iSpecimen Inc. | ISPC | Grant | Option | 10k | $1.41 | $14.1k | | 01/03/2023 |
| 01/01/2023 | iSpecimen Inc. | ISPC | Grant | | 125 | $0.00 | $0 | | 01/01/2023 |
| 01/13/2020 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Non-qualified stock option (right to buy) | 60k | $8.39 | $503.4k | | 01/13/2020 |
| 07/24/2019 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Common Stock | 300k | $0.00 | $0 | | 07/24/2019 |
| 05/22/2018 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Employee Stock Option (right to buy) | 50k | $5.56 | $278k | | 05/22/2018 |
| 02/08/2018 | NeuroBo Pharmaceuticals, Inc. | GEMP | Purchase | Common Stock | 71.4k | $7.00 | $500k | Held by Excel Venture Fund II, L.P. | 02/08/2018 |
| 01/29/2018 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Employee Stock Option (right to buy) | 60k | $10.44 | $626.4k | | 01/29/2018 |
| 05/30/2017 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Employee Stock Option (right to buy) | 60k | $10.26 | $615.6k | | 05/30/2017 |
| 03/10/2017 | NeuroBo Pharmaceuticals, Inc. | GEMP | Purchase | Warrant to Purchase Common Stock | 39.6k | $10.40 | $411.8k | Held by Excel Venture Fund II, L.P. | 03/10/2017 |
| 03/10/2017 | NeuroBo Pharmaceuticals, Inc. | GEMP | Purchase | Common Stock | 52.8k | $9.47 | $500k | Held by Excel Venture Fund II, L.P. | 03/10/2017 |
| 08/10/2016 | NeuroBo Pharmaceuticals, Inc. | GEMP | Conversion | 8% Convertible Subordinated Promissory Note | 0 | $6.71 | $0 | Held by Excel Venture Fund II, L.P. | 08/10/2016 |
| 08/10/2016 | NeuroBo Pharmaceuticals, Inc. | GEMP | Purchase | Common Stock | 500k | $10.00 | $5M | Held by Excel Venture Fund II, L.P. | 08/10/2016 |
| 08/10/2016 | NeuroBo Pharmaceuticals, Inc. | GEMP | Conversion | Common Stock | 306k | $6.71 | $2.1M | Held by Excel Venture Fund II, L.P. | 08/10/2016 |
| 08/04/2016 | NeuroBo Pharmaceuticals, Inc. | GEMP | Grant | Stock Option (right to buy) | 60k | $10.00 | $600k | | 08/04/2016 |
| 06/12/2014 | TETRAPHASE PHARMACEUTICALS INC | TTPH | Grant | Stock option (right to buy) | 10k | $11.26 | $112.6k | | 06/12/2014 |
| 05/19/2014 | TETRAPHASE PHARMACEUTICALS INC | TTPH | Purchase | Common Stock | 25k | $9.24 | $231k | | 05/19/2014 |
| 03/25/2013 | TETRAPHASE PHARMACEUTICALS INC | TTPH | Grant | Non-qualified stock option (right to buy) | 20k | $7.07 | $141.4k | | 03/25/2013 |
| 03/25/2013 | TETRAPHASE PHARMACEUTICALS INC | TTPH | Conversion | Series C Convertible Participating Preferred Stock | 28.2M | $0.00 | $0 | By Excel Medical Fund, L.P. | 03/25/2013 |
| 03/25/2013 | TETRAPHASE PHARMACEUTICALS INC | TTPH | Purchase | Common Stock | 496.1k | $7.00 | $3.5M | By Excel Medical Fund, L.P. | 03/25/2013 |
| 03/25/2013 | TETRAPHASE PHARMACEUTICALS INC | TTPH | Conversion | Common Stock | 972.4k | $0.00 | $0 | By Excel Medical Fund, L.P. | 03/25/2013 |